CN Patent
CN110638963A — 一种可降解缓释药物组合物及制备方法
Assigned to Huisheng Medical Science And Technology (xuzhou) Co Ltd · Expires 2020-01-03 · 6y expired
What this patent protects
一种可降解缓释药物,其特征在于:包括PHA 26‑38重量份、聚乙二醇12‑19重量份、活性药物45‑50重量份。有益效果是解决目前便秘药物损耗大、效果衰退快的问题。
USPTO Abstract
一种可降解缓释药物,其特征在于:包括PHA 26‑38重量份、聚乙二醇12‑19重量份、活性药物45‑50重量份。有益效果是解决目前便秘药物损耗大、效果衰退快的问题。
Drugs covered by this patent
- Risperdal (risperidone) · Johnson & Johnson (Janssen)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.